Perfluoroalkyl chemicals and human fetal development: An epidemiologic review with clinical and toxicological perspectives

Reproductive Toxicology

Volumn 27, Issue 3-4, 2009, Pages 212-230

  Olsen, Geary W ^a   Butenhoff, John L ^a   Zobel, Larry R ^a  

^a 3M COMPANY   (United States)

Author keywords

Birth weight; Epidemiology; Fecundity; Human fetal development; Perfluoroalkyls; Perfluorooctanesulfonate; Perfluorooctanoate; PFOA; PFOS

Indexed keywords

DRINKING WATER; PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ANTHROPOMETRY; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; DOSE RESPONSE; FETUS DEVELOPMENT; GROWTH RETARDATION; HEALTH HAZARD; POSTNATAL GROWTH; WATER CONTAMINATION;

ALABAMA; ALKANESULFONIC ACIDS; BIRTH WEIGHT; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FERTILITY; FETAL BLOOD; FETAL DEVELOPMENT; FLUOROCARBONS; GESTATIONAL AGE; HUMANS; OCCUPATIONAL EXPOSURE; OCTANOIC ACIDS; OHIO; PREGNANCY;

MUS; RATTUS;

EID: 64949134049     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2009.02.001     Document Type: Article

References (91)

1. OECD. Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. Organization for Economic Co-operation and Development; November 21, 2002 [available at http://www.oecd.org/dataoecd/23/18/23822880.pdf].
2. Lau C., Butenhoff J.L., and Rogers J.M. The developmental toxicity of perfluororalkyl acids and their derivatives. Toxicol Appl Pharmacol 198 (2004) 231-241
3. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., and Seed J. Perfluoroalkyl acids: a review of monitoring toxicological findings. Toxicol Sci 99 (2007) 366-394
4. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74 (2003) 382-392
5. Luebker D.J., York R.G., Hansen K.J., Moore J.A., and Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 215 (2005) 149-169
6. Butenhoff J.L., Kennedy G.L., Frame S.R., O'Connor J.C., and York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196 (2004) 95-116
7. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., and Lindstrom A.B. et al Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90 (2006) 510-518
8. 3M Company. Health and environmental assessment of perfluorooctane sulfonic acid and its salts. U.S. EPA docket AR-226-1486. Washington, DC: U.S. Environmental Protection Agency.
9. Butenhoff J.L., Gaylor D.W., Moore J.A., Olsen G.W., Rodricks J., Mandel J.H., et al. Characterization of risk for general population exposure to perfluorooctanoate. Reg Toxicol Pharmacol 39 (2004) 363-380
10. Tan Y.M., Clewell H.J., and Andersen M.E. Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis. Toxicol Lett 177 (2008) 38-47
11. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., et al. Perfluorooctanoic acid-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferators-activated receptor-alpha. Toxicol Sci 98 (2007) 571-581
12. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., et al. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator-activated receptor-alpha (PPARα) in the mouse. Reprod Toxicol 27 (2009) 258-265
13. Grasty R.C., Bjork J.A., Wallace K.B., Lau C.S., and Rogers J.M. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res 74 (2005) 405-416
14. Lehmler H.J., Xie W., Bothun G.D., Bummer P.M., and Knutson B.L. Mixing of perfluorooctanesulfonic acid (PFOS) potassium salt with dipalmitoyl phosphatidylcholine (DPPC). Colloids Surf B Biointerfaces 51 (2006) 25-29
15. Butenhoff J.L., Olsen G.W., and Pfahles-Hutchens A. The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect 114 (2006) 1776-1782
16. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111 (2003) 1892-1901
17. Olsen G.W., Church T.R., Hansen K.J., Burris J.M., Butenhoff J.L., Mandel J.H., et al. Quantitative evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J Child Health 2 (2004) 55-76
18. Olsen G.W., Church T.R., Larson E.B., van Belle G., Lundberg J.K., Hansen K.J., et al. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 54 (2004) 1599-1611
19. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., and Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115 (2007) 1596-1602
20. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115 (2007) 1298-1305
21. Inoue K., Okada F., Ito R., Kato S., Saski S., Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112 (2004) 1204-1207
22. Midasch O., Drexler H., Hart N., Beckmann M.W., and Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80 (2007) 643-648
23. So M.K., Yamashita N., Taniyasu S., Jiang Q., Giesy J.P., Chen K., et al. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 40 (2006) 2924-2929
24. Kärrman A., Ericson I., van Bavel B., Darnerud P.O., Aune M., Glynn A., et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 115 (2007) 226-230
25. Tao L., Kannan K., Wong C.M., Arcaro K.F., and Butenhoff J.L. Perfluorinated compounds in human milk from Massachusetts, USA. Environ Sci Technol 42 (2008) 3096-3101
26. Völkel W., Genzel-Boroviczeny O., Demmelmair H., Gebauer C., Koletzko B., Twardella D., et al. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int J Hyg Environ Health 211 (2008) 440-446
27. De Silva A.O., and Mabury S.A. Isomer distribution of perfluorocarboxylates in human blood: potential correlation to source. Environ Sci Technol 40 (2006) 2903-2909
28. Prevedouros K., Cousins I.T., Buck R.C., and Korzeniowski S.H. Sources, fat and transport of perfluorocarboxylates. Environ Sci Technol 40 (2006) 32-34
29. Washburn S.T., Bingman T.S., Braithwaite S.K., Buck R.C., Buxton L.W., Clewell H.J., et al. Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles. Environ Sci Technol 39 (2005) 3904-3910
30. Tittlemier S., Pepper K., Seymour C., Moisey J., Bronson R., Cao X.L., et al. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 55 (2007) 3203-3210
31. Fromme H., Schlummer M., Möller A., Gruber L., Wolz G., Ungewiss J., et al. Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data. Environ Sci Technol 41 (2007) 7928-7933
32. Ericson I., Marti-Cid R., Nadal M., Van Bavel B., Lindstrom G., and Domingo J.L. Human exposure to perfluorinated chemicals through the diet: intake of perfluorinated compounds in food from the Catalan (Spain) market. J Agric Food Chem 56 (2008) 1787-1794
33. Halldorsson T., Fei C., Olsen J., Lipworth L., McLaughlin J., and Olsen S.F. Dietary predictors of perfluorinated chemicals: a study from the Danish National Birth Cohort. Environ Sci Technol 42 (2008) 8971-8977
34. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., and Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48 (2006) 759-770
35. Harada K., Saito N., Sasaki K., Inoue K., and Koizumi A. Perfluorooctane sulfonate contamination of drinking water in the Tama River, Japan: estimated effects on resident serum levels. Bull Environ Contam Toxicol 71 (2003) 31-36
36. Skutlarek D., Exner M., and Farber H. Perfluorinated surfactants in surface and drinking waters. Environ Sci Pol Res 71 13 (2006) 299-307
37. Moriwaki H., Takatah Y., and Arakawa R. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in vacuum cleaner dust collected in Japanese homes. J Environ Monit 5 (2003) 753-757
38. Schoeib M., Harner T., Wilford B., Jones K.C., and Zhu J. Perfluorinated sulfonamides in indoor and outdoor air and indoor dust: occurrence, partitioning and human exposure. Environ Sci Technol 39 (2005) 6599-6606
39. Kubwabo C., Stewart B., Zhu J., and Marro L. Occurrence of perfluorosulfonates and other perfluorochemicals in dust from selected homes in the city of Ottawa, Canada. J Environ Monit 7 (2005) 1074-1078
40. Strynar M.J., and Lindstrom A.B. Perfluorinated compounds in house dust from Ohio and North Carolina, USA. Environ Sci Technol 42 (2008) 3751-3756
41. Murakami M., and Takada H. Perfluorinated surfactants (PFSs) in size-fractionated street dust in Tokyo. Chemosphere 73 (2008) 1172-1177
42. Apelberg BJ. Fetal exposure to perfluorinated compounds: distributions and determinants of exposure and relationships with weight and size at birth. Doctoral dissertation. Baltimore, MD: Johns Hopkins University; August 2006.
43. Apelberg B.J., Goldman L.R., Calafat A.M., Herbstman J.B., Kuklenyik Z., Heidler J., et al. Determinants of fetal exposure to perfluorinated compounds in Baltimore, Maryland. Environ Sci Technol 41 (2007) 3891-3897
44. Apelberg B.J., Whitter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115 (2007) 1670-1676
45. Fei C., McLaughlin J.K., Tarone R.E., and Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115 (2007) 1677-1682
46. Fei C., McLaughlin J.K., Tarone R.E., and Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 168 (2008) 66-72
47. Fei C., McLaughlin J.K., Lipworth L., and Olsen J. Prenatal exposure to PFOA and PFOS and maternally reported developmental milestones in infancy. Environ Health Perspect 116 (2008) 1391-1395
48. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Steward B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108 (2008) 56-62
49. Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect, 2009, [doi:10.1289/ehp.11681].
50. Nolan L.A., Nolan H.M., Schofer F.S., Rodway N.V., and Emmett E.A. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27 (2009) 231-238
51. Grice M.M., Alexander B.H., Hoffbeck R., and Kampa D.M. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 49 (2007) 722-729
52. Olsen G.W., Burlew M.M., Marshall J.C., Burris J.M., and Mandel J.H. Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. J Occup Environ Med 46 (2004) 837-846
53. Begley T.H., White K., Honigfort P., Twaroski M.L., Neches R., and Walker R.A. Perfluorochemicals: potential sources of and migration from food packaging. Food Addit Contam 22 (2005) 1023-1031
54. Sinclair E., Kim S.K., Akinleye H.B., and Kannan K. Quantitation of gas-phase perfluoroalkyl surfactants and fluorotelomer alcohols released from nonstick cookware and microwave popcorn bags. Environ Sci Technol 41 (2007) 1180-1185
55. Barton C.A., Butler L.E., Zarzecki C.J., Flaherty J., and Kaiser M. Characterizing perfluorooctanoate in ambient air near the fence line of a manufacturing facility: comparing modeled and monitored values. J Air Waste Manag Assoc 56 (2006) 48-55
56. C8 Health Project. West Virginia University Data Hosting Website. Available at http://www.hsc.wvu.edu/som/cmed/c8/index.asp. Accessed 12 December 2008.
57. Olsen GW, Logan PW, Simpson CA, Hansen KJ, Burris JM, Burlew MM, et al. Fluorochemical exposure assessment of Decatur chemical and film plant employees. 3M final report; August 11, 1999 [available at U.S. EPA public docket AR-226-0950].
58. Olsen G.W., Burris J.M., Mandel J.H., and Zobel L.R. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med 41 (1999) 799-806
59. Olsen G.W., Burris J.M., Burlew M.M., and Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45 (2003) 260-270
60. Olsen G.W., and Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81 (2007) 231-246
61. Alexander B.H., Olsen G.W., Burris J.M., Mandel J.H., and Mandel J.S. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 60 (2003) 722-729
62. Alexander B.H., and Olsen G.W. Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 17 (2007) 471-478
63. National vital statistics report. Births: final data for 2005, vol. 56. NVSR; 2007. p. 81-2.
64. Alabama Dept Public Health. Alabama vital statistics; 2005 [available online at http://ph.state.al.us/Chs/HealthStatistics/AVS%2005%20FINAL%20BOOK.pdf].
65. Fewell Z., Smith G.D., and Sterne J.A.C. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol 166 (2007) 646-655
66. Spliethoff H.M., Tao L., Shaver S.M., Aldous K.M., Pass K.A., Kannan K., et al. Use of newborn screening program blood spots for exposure assessment: declining levels of perfluorinated compounds in New York state infants. Environ Sci Technol 42 (2008) 5361-5367
67. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., Boyd T.M., et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 42 (2008) 4989-4995
68. Savitz D.A. Biomarkers of perfluorinated chemicals and birth weight. Environ Health Perspect 115 (2007) A528-A529
69. Wilcox A.J. On the importance - and the unimportance - of birth weight. Int J Epidemiol 30 (2001) 1233-1241
70. Clapp J.F., Rizk K.H., Appelby-Wineberg S.K., and Crass J.R. Second-trimester placental volumes predict birth weight at term. J Soc Gynecol Investig 2 (1995) 19-22
71. Thame M., Osmond C., Wilks R., Bennett F.I., and Forrester T.E. Second-trimester placental volume and infant size at birth. Obstet Gynecol 98 (2001) 279-283
72. Thame M., Osmond C., Bennett F., Wilks R., and Forrester T. Fetal growth is directly related to maternal anthropometry and placental volume. Eur J Clin Nutr 58 (2004) 894-900
73. Scialli A. Perfluoroalkane acids and fetal growth [letter]. Environ Health Perspect 116 (2008) A238
74. Mathews F., Youngman L., and Neil A. Maternal circulating nutrient concentration in pregnancy: implications for birth and placental weights of term infants. Am J Clin Nutr 79 (2004) 103-110
75. Scanlon K.S., Yip R., Schieve L.A., and Cogswell M.E. High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age. Obstet Gynecol 96 (2000) 741-748
76. Steer P.J. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr 71 (2000) 1285S-1287S
77. Whitaker P.G., Macphail S., and Lind T. Serial hematologic changes and pregnancy outcome. Obstet Gynecol 88 (1996) 33-39
78. Wolf H., Oosting H., and Treffers P.E. A longitudinal study of the relationship between placental growth and fetal growth as measured by ultrasonography. Am J Obstet Gynecol 161 (1989) 1140-1145
79. Abrams B., and Selvin S. Maternal weight gain pattern and birth weight. Obstet Gynecol 86 (1995) 163-169
80. Pickett K.E., Abrams B., and Selvin S. Maternal height, pregnancy weight gain, and birthweight. Am J Hum Biol 12 (2000) 682-687
81. Frederiksen M.C. Physiologic changes in pregnancy and their effect on drug disposition. Semin Perinatol 25 (2001) 120-123
82. Bofetta P., McLaughlin J.K., La Vecchia C., Tarone R.E., Lipworth L., and Blot W.J. False-positive results in cancer epidemiology: a plea for epistemological modesty. JNCI 100 (2008) 988-995
83. Ioannidis J.A. Why most discovered true associations are inflated. Epidemiology 19 (2008) 640-648
84. C8 Science Panel. Community study summary. Available at http://www.c8sciencepanel.org/studies.html. Accessed December 14, 2008.
85. University of British Columbia. Chemicals, health and pregnancy. Available at http://web.cher.ubc.ca/chirp/team.html.
86. Andersen M.E., Butenhoff J.L., Shang S.C., Farrar D.G., Kennedy G.L., Lau C., et al. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 102 (2008) 3-14
87. Herbstman J.B., Sjödin A., Apelberg B.J., Witter F.R., Halden R.U., Patterson D.G., et al. Birth delivery mode modifies the associations between prenatal PCB and PBDE and neonatal thyroid hormone levels. Environ Health Perspect 115 (2007) 1794-1800
88. Fei C., McLaughlin J.K., Lipworth L., and Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 1 (2009) 1-6
89. Greenland S., Pearl J., and Robins J.M. Causal diagrams for epidemiologic research. Epidemiology 10 (1999) 37-48
90. Austin M.E., Kasturi B.S., Barber M., Kannan K., MohanKumar P.S., and MohanKumar S.M. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect 111 (2003) 1485-1489
91. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., and Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215 (2005) 126-148